Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (“Vivos” or the ...
Call Scheduled for Thursday, November 14, 2024 at 5:00 pm ETLITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical ...
Contrary to popular belief, children aren't better at learning new skills than adults. Indeed, young adults seem to learn faster than kids -- but also tend to forget more quickly. Here, better sleep ...
The aura6000 is an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe obstructive sleep apnea. In the OSPREY study, apnea-hypopnea index and oxygen ...